Drugs / Midazolam injection
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03490903 Background | Jun 2018 | anxiety, atherosclerosis, coronary artery disorder | University of California, Los Angeles | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Midazolam injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03490903 ↗ |
| Route | Intravenous | “Intravenous midazolam injection dosages are determined by the physician operator, and administered by the circulating nurse.” NCT03490903 ↗ |